{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:04:10Z","timestamp":1791842650887,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u4e2d\u56fd","award":["National Key Research and Development Plan Project(2018YFC2001904)"],"award-info":[{"award-number":["National Key Research and Development Plan Project(2018YFC2001904)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-024-02714-3","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:02:34Z","timestamp":1726113754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of esmolol in sepsis: a meta-analysis based on randomized controlled trials"],"prefix":"10.1186","volume":"24","author":[{"given":"Ya","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshan","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"8","key":"2714_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762\u201374.","journal-title":"JAMA"},{"issue":"7","key":"2714_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303\u201310.","journal-title":"Crit Care Med"},{"issue":"13","key":"2714_CR3","doi-asserted-by":"publisher","first-page":"e0263","DOI":"10.1097\/MD.0000000000010263","volume":"97","author":"HS Jeong","year":"2018","unstructured":"Jeong HS, Lee TH, Bang CH, et al. Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: a comparative retrospective study. Medicine. 2018;97(13):e0263.","journal-title":"Medicine"},{"issue":"5","key":"2714_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/MCC.0b013e32834a4aeb","volume":"17","author":"WJ Wiersinga","year":"2011","unstructured":"Wiersinga WJ. Current insights in sepsis: from pathogenesis to new treatment targets. Curr Opin Crit Care. 2011;17(5):480\u20136.","journal-title":"Curr Opin Crit Care"},{"key":"2714_CR5","doi-asserted-by":"crossref","unstructured":"R, HD, J T, et al. Beta-adrenergic blockade in critical illness. Front Pharmacol. 2021;12:2024\u201303.","DOI":"10.3389\/fphar.2021.735841"},{"key":"2714_CR6","doi-asserted-by":"crossref","unstructured":"Guo CA, Ma L, Su XL, et al. Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-\u03baB-p65 in the early-stage sepsis rats. Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol. 2020;31(4):331\u201341.","DOI":"10.5152\/tjg.2020.19341"},{"issue":"11","key":"2714_CR7","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00134-011-2326-x","volume":"37","author":"K Mori","year":"2011","unstructured":"Mori K, Morisaki H, Yajima S, et al. Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intensive Care Med. 2011;37(11):1849\u201356.","journal-title":"Intensive Care Med"},{"issue":"16","key":"2714_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683.","journal-title":"JAMA"},{"issue":"8","key":"2714_CR9","first-page":"5","volume":"35","author":"W Xuehua Gao","year":"2015","unstructured":"Xuehua Gao W, Cao Y, Guan, et al. Protective effect of esmolol on myocardial injury in septic patients. Chin J Crit Care Med. 2015;35(8):5.","journal-title":"Chin J Crit Care Med"},{"issue":"5","key":"2714_CR10","first-page":"390","volume":"29","author":"M Shupeng Wang","year":"2017","unstructured":"Shupeng Wang M, Li J, Duan, et al. Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock. Chin Crit Care Med. 2017;29(5):390\u20135.","journal-title":"Chin Crit Care Med"},{"issue":"17","key":"2714_CR11","first-page":"1317","volume":"99","author":"X Huan Liu","year":"2019","unstructured":"Huan Liu X, Ding S, Zhang, et al. Effect of esmolol in septic patients with tachycardia: a randomized clinical trial. Natl Med J China. 2019;99(17):1317\u201322.","journal-title":"Natl Med J China"},{"issue":"4","key":"2714_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4274\/tybd.galenos.2019.04934","volume":"18","author":"ES Bing\u00fcl","year":"2020","unstructured":"Bing\u00fcl ES, Orhun G, Ergin \u00d6zcan P, et al. Effect of heart rate control on oxygenation and vasopressor need in sepsis and septic shock-a pilot randomized controlled study. Turkish J Intensive Care. 2020;18(4):195\u2013204.","journal-title":"Turkish J Intensive Care"},{"key":"2714_CR13","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"2714_CR14","doi-asserted-by":"crossref","unstructured":"Levy MM, Fink MP, Marshall JC et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250\u20131256.","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"2714_CR15","doi-asserted-by":"crossref","unstructured":"Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101(6):1644\u20131655.","DOI":"10.1378\/chest.101.6.1644"},{"key":"2714_CR16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"7","key":"2714_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09622802231172043","volume":"32","author":"J Shi","year":"2023","unstructured":"Shi J, Luo D, Wan X, et al. Detecting the skewness of data from the sample size and the five-number summary and its application in meta-analysis. Stat Methods Med Res. 2023;32(7):1338\u201360.","journal-title":"Stat Methods Med Res"},{"key":"2714_CR18","unstructured":"X DL. W, J L, Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res, 2018, 27(6)."},{"issue":"5","key":"2714_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synthesis Methods. 2020;11(5):641\u201354.","journal-title":"Res Synthesis Methods"},{"key":"2714_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and\/ or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2714_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12871-023-01983-8","volume":"23","author":"J Wang","year":"2023","unstructured":"Wang J, Gao X, He Z, et al. Evaluating the effects of esmolol on cardiac function in patients with septic cardiomyopathy by speck-tracking echocardiography\u2014a randomized controlled trial. BMC Anesthesiol. 2023;23(1):51.","journal-title":"BMC Anesthesiol"},{"issue":"9","key":"2714_CR22","first-page":"759","volume":"27","author":"W Xinqiang Liu","year":"2015","unstructured":"Xinqiang Liu W, Huang M, Wen, et al. Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate. Chin Crit Care Med. 2015;27(9):759\u201363.","journal-title":"Chin Crit Care Med"},{"issue":"10","key":"2714_CR23","first-page":"714","volume":"26","author":"Z Shengqiang Yang","year":"2014","unstructured":"Shengqiang Yang Z, Liu W, Yang, et al. Effects of the \u03b2- blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study. Chin Crit Care Med. 2014;26(10):714\u20137.","journal-title":"Chin Crit Care Med"},{"issue":"5","key":"2714_CR24","first-page":"5","volume":"36","author":"W Wenxin Zeng","year":"2016","unstructured":"Wenxin Zeng W, Jiang C, Huang, et al. Effect of adrenergic \u03b21-antagonists on hemodynamic and inflammatory responses in patients with septic shock. Chin J Crit Care Med. 2016;36(5):5.","journal-title":"Chin J Crit Care Med"},{"issue":"1","key":"2714_CR25","first-page":"15","volume":"12","author":"C Chun Yang","year":"2019","unstructured":"Chun Yang C, Wang T, Chen, et al. Clinical study on the cardio protection of esmolol in patients with septic shock. Chin J Crit Care Med (Electronic Edition). 2019;12(1):15\u20139.","journal-title":"Chin J Crit Care Med (Electronic Edition)"},{"issue":"1","key":"2714_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s42077-020-00107-5","volume":"12","author":"RR Gadallah","year":"2020","unstructured":"Gadallah RR, Aboseif EMK, Ibrahim DA, et al. Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial. Ain-Shams J Anesthesiology. 2020;12(1):57.","journal-title":"Ain-Shams J Anesthesiology"},{"issue":"4","key":"2714_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/SHK.0000000000001905","volume":"57","author":"MN Cocchi","year":"2022","unstructured":"Cocchi MN, Dargin J, Chase M, et al. Esmolol to treat the hemodynamic effects of septic shock: a randomized controlled trial. Shock. 2022;57(4):508\u201317.","journal-title":"Shock"},{"key":"2714_CR28","unstructured":"Yihua Zhou H, Yuan Y, Yuan et al. Effect of esmolol on left ventricular function and prognosis in patients with septic shock. Chin J Emerg Med, 2019(1): 100\u20133."},{"issue":"12","key":"2714_CR29","first-page":"57","volume":"17","author":"A Jie Zhou","year":"2019","unstructured":"Jie Zhou A, Yang W, Tao. Effects of esmolol on cardiac function, inflammatory markers and prognosis in elderly patients with septic shock. Clin Medication J. 2019;17(12):57\u201360.","journal-title":"Clin Medication J"},{"issue":"7","key":"2714_CR30","first-page":"5","volume":"32","author":"Songlin Li","year":"2017","unstructured":"Songlin Li. Clinical study on esmolol in improvement of septic shock cardiac function. Drugs Clin. 2017;32(7):5.","journal-title":"Drugs Clin"},{"issue":"4","key":"2714_CR31","first-page":"4","volume":"31","author":"R Zhang","year":"2022","unstructured":"Zhang R, Liu H. Effect of esmolol on the prognosis of patients with septic shock: a meta-analysis of randomized controlled trials. Chin J Emerg Med. 2022;31(4):4.","journal-title":"Chin J Emerg Med"},{"issue":"27","key":"2714_CR32","doi-asserted-by":"publisher","first-page":"e29820","DOI":"10.1097\/MD.0000000000029820","volume":"101","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen C, Liu Y, et al. Benefits of esmolol in adults with sepsis and septic shock: an updated meta-analysis of randomized controlled trials. Medicine. 2022;101(27):e29820.","journal-title":"Medicine"},{"issue":"6","key":"2714_CR33","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","volume":"159","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa D, Sato R, Prasitlumkum N, et al. Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation. Chest. 2021;159(6):2289\u2013300.","journal-title":"Chest"},{"key":"2714_CR34","doi-asserted-by":"publisher","first-page":"154916","DOI":"10.1016\/j.cyto.2019.154916","volume":"126","author":"J Li","year":"2020","unstructured":"Li J, Sun W, Guo Y, et al. Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies. Cytokine. 2020;126:154916.","journal-title":"Cytokine"},{"key":"2714_CR35","doi-asserted-by":"publisher","first-page":"682232","DOI":"10.3389\/fphar.2021.682232","volume":"12","author":"P Huang","year":"2021","unstructured":"Huang P, Zheng X, Liu Z, et al. The efficacy and safety of esmolol for septic shock: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2021;12:682232.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2714_CR36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajem.2017.11.013","volume":"36","author":"P Liu","year":"2018","unstructured":"Liu P, Wu Q, Tang Y, et al. The influence of esmolol on septic shock and sepsis: a meta-analysis of randomized controlled studies. Am J Emerg Med. 2018;36(3):470\u20134.","journal-title":"Am J Emerg Med"},{"issue":"11","key":"2714_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40261-015-0325-3","volume":"35","author":"Z Wang","year":"2015","unstructured":"Wang Z, Wu Q, Nie X, et al. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial. Clin Drug Investig. 2015;35(11):707\u201316.","journal-title":"Clin Drug Investig"},{"issue":"5","key":"2714_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.pan.2016.05.395","volume":"16","author":"L Zhang","year":"2016","unstructured":"Zhang L, Nie Y, Zheng Y, et al. Esmolol attenuates lung injury and inflammation in severe acute pancreatitis rats. Pancreatology: Official J Int Association Pancreatology (IAP). 2016;16(5):726\u201332. \u2026 et al.].","journal-title":"Pancreatology: Official J Int Association Pancreatology (IAP)"},{"issue":"10","key":"2714_CR39","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/01.CCM.0000182796.11329.3B","volume":"33","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Morisaki H, Serita R, et al. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med. 2005;33(10):2294\u2013301.","journal-title":"Crit Care Med"},{"key":"2714_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fphar.2020.00210","volume":"11","author":"H Lin","year":"2020","unstructured":"Lin H, Wang W, Lee M, et al. Current status of septic cardiomyopathy: basic science and clinical progress. Front Pharmacol. 2020;11:210.","journal-title":"Front Pharmacol"},{"key":"2714_CR41","doi-asserted-by":"crossref","unstructured":"Beesley SM, Sarah J, Weber GS, ToddNikravan SG, Lanspa CK, Shahul MJ. SajidBrown Septic Cardiomyopathy Crit care Med, 2018, 46(4).","DOI":"10.1097\/CCM.0000000000002851"},{"issue":"2","key":"2714_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","volume":"155","author":"L Martin","year":"2019","unstructured":"Martin L, Derwall M, Al Zoubi S, et al. The Septic Heart: current understanding of molecular mechanisms and clinical implications. Chest. 2019;155(2):427\u201337.","journal-title":"Chest"},{"issue":"5","key":"2714_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/SHK.0000000000002104","volume":"59","author":"Y Ma","year":"2023","unstructured":"Ma Y, Cheng Z, Zheng Y, et al. Low dose of esmolol attenuates sepsis-induced immunosuppression via modulating T-lymphocyte apoptosis and differentiation. Shock (Augusta Ga). 2023;59(5):771\u20138.","journal-title":"Shock (Augusta Ga)"},{"key":"2714_CR44","doi-asserted-by":"crossref","unstructured":"Manon D, Eug\u00e9nie H, Huguette L et al. The \u03b21 -adrenergic receptor contributes to sepsis-induced immunosuppression through modulation of regulatory T-cell inhibitory function. Crit Care Med, 2022, 50(9).","DOI":"10.1097\/CCM.0000000000005503"},{"issue":"2","key":"2714_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccm.2016.01.014","volume":"37","author":"KE Fenton","year":"2016","unstructured":"Fenton KE, Parker MM. Cardiac function and dysfunction in sepsis. Clin Chest Med. 2016;37(2):289\u201398.","journal-title":"Clin Chest Med"},{"issue":"4","key":"2714_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jjcc.2020.05.001","volume":"76","author":"D Harada","year":"2020","unstructured":"Harada D, Asanoi H, Noto T, et al. The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction. J Cardiol. 2020;76(4):325\u201334.","journal-title":"J Cardiol"},{"issue":"14","key":"2714_CR47","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4103\/0366-6999.185856","volume":"129","author":"W Du","year":"2016","unstructured":"Du W, Wang XT, Long Y, et al. Efficacy and safety of esmolol in treatment of patients with septic shock. Chin Med J. 2016;129(14):1658\u201365.","journal-title":"Chin Med J"},{"issue":"5","key":"2714_CR48","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.surg.2005.10.010","volume":"139","author":"DC Gore","year":"2006","unstructured":"Gore DC, Wolfe RR. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery. 2006;139(5):686\u201394.","journal-title":"Surgery"},{"issue":"4","key":"2714_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/0267659116681437","volume":"32","author":"E Bignami","year":"2017","unstructured":"Bignami E, Guarnieri M, Franco A, et al. Esmolol before Cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion. 2017;32(4):313\u201320.","journal-title":"Perfusion"},{"issue":"4","key":"2714_CR50","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.jvca.2020.12.029","volume":"35","author":"A Zangrillo","year":"2021","unstructured":"Zangrillo A, Bignami E, No\u00e8 B, et al. Esmolol in Cardiac surgery: a Randomized Controlled Trial. J Cardiothorac Vasc Anesth. 2021;35(4):1106\u201314.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"9","key":"2714_CR51","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1053\/j.jvca.2023.05.013","volume":"37","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Belletti A, D\u2019Andria Ursoleo J, Salvati S, Landoni G. Norepinephrine Dose should be reported as Base Equivalence in Clinical Research manuscripts. J Cardiothorac Vasc Anesth. 2023;37(9):1523\u20134.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2714_CR52","doi-asserted-by":"crossref","unstructured":"Salvati S, D\u2019Andria Ursoleo J, Belletti A et al. Norepinephrine Salt formulations and Risk of Therapeutic Error: results of a National Survey. J Cardiothorac Vasc Anesth Published Online May 27, 2024.","DOI":"10.1053\/j.jvca.2024.05.031"},{"key":"2714_CR53","doi-asserted-by":"crossref","unstructured":"Salvati S, D\u2019Andria Ursoleo J, Landoni G, Belletti A. In Reply to letter to the editor: the alphabet soup of norepinephrine doses. J Cardiothorac Vasc Anesth Published Online April 16, 2024.","DOI":"10.1053\/j.jvca.2024.04.020"},{"issue":"1","key":"2714_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13054-024-05011-0","volume":"28","author":"S Morales","year":"2024","unstructured":"Morales S, Wendel-Garcia PD, Ibarra-Estrada M, et al. The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients. Crit Care. 2024;28(1):216.","journal-title":"Crit Care"},{"issue":"4","key":"2714_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","volume":"52","author":"PM Wieruszewski","year":"2024","unstructured":"Wieruszewski PM, Leone M, Kaas-Hansen BS, et al. Position paper on the reporting of norepinephrine formulations in critical care from the society of critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force. Crit Care Med. 2024;52(4):521\u201330.","journal-title":"Crit Care Med"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02714-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-024-02714-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02714-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T05:02:37Z","timestamp":1726117357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-024-02714-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2714"],"URL":"https:\/\/doi.org\/10.1186\/s12871-024-02714-3","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}